Experimental onchocerciasis chimpanzees Cell-mediated immune responses production effects Onchocerca volvulus infection Nine eighteen chimpanzees infective third-stage larvae Onchocerca developed patent infection microfilariae skin biopsies infected chimpanzees vitro cellular reactivity volvulus adult worm-derived Ag OvAg exposure third-stage larvae prepatency vitro cellular responses OvAg mf positive patent animals patency values different infection non-patent chimpanzees cellular responses infection Stimulation PBMC vitro bacterial Ag mitogen differences experimental groups months addition exogenous impaired responses PBMC OvAg patent animals Exogenous additive increase cellular response OvAg nonpatent mitogenic effect OvAg patent animals Selective depletion adherent suppressor/cytotoxic NK cells use autologous serum effect antigenic mitogenic cellular responsiveness OvAg-induced production patency whereas production patent nonpatent control chimpanzees summary data demonstrate experimental volvulus infection chimpanzees substantial cell-mediated immune response patent chimpanzees OvAg-specific cellular hyporesponsiveness onset patency due decreased production responsiveness 